Dr Rahul Bhargava

Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Contact Us

Frequently Asked Questions (FAQ) :

Acute Lymphoblastic Leukemia (ALL) is a type of cancer that affects the blood and bone marrow. It involves the rapid growth of immature white blood cells, called lymphoblasts. This leads to a decrease in healthy blood cells, which can result in symptoms like fatigue, infections, and easy bruising.

Symptoms of ALL can include fever, frequent infections, easy bruising or bleeding, pale skin, swollen lymph nodes, bone or joint pain, and fatigue. Some people may also experience weight loss, night sweats, or a swollen abdomen.

    • Diagnosis typically involves blood tests, bone marrow biopsies, and imaging tests. A doctor may look for high levels of immature white blood cells in the blood or bone marrow. Genetic testing may also be used to identify specific mutations associated with ALL.
  •  

Acute Lymphoblastic Leukemia

About Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia (ALL) is a fast-growing cancer of the blood and bone marrow. It affects the white blood cells, impairing the body’s ability to fight infections. While it is more common in children, adults can also develop ALL. Early diagnosis and treatment are crucial for a favorable outcome.

Types of Acute Lymphoblastic Leukemia

ALL is classified into subtypes based on the type of lymphocyte (B-cell or T-cell) that is affected:

  • B-cell ALL: The most common type, originating in immature B-lymphocytes.
  • T-cell ALL: A less common form that develops in immature T-lymphocytes.
  • Philadelphia chromosome-positive ALL: A genetic mutation seen in some patients with ALL, influencing treatment options.

Causes of Acute Lymphoblastic Leukemia

The exact cause of ALL is not fully understood, but several factors increase the risk:

  • Genetic predisposition: Family history or inherited genetic syndromes like Down syndrome.
  • Exposure to radiation or chemicals: Prolonged exposure to high doses of radiation or certain chemicals.
  • Immune system disorders: Conditions that weaken the immune system.

Symptoms of Acute Lymphoblastic Leukemia

Recognizing the symptoms early can significantly improve treatment outcomes. Common symptoms include:

  • Persistent fatigue or weakness.
  • Frequent infections or unexplained fevers.
  • Easy bruising or bleeding.
  • Swollen lymph nodes or abdominal discomfort.
  • Bone pain or tenderness.
  • Pale skin or shortness of breath.

Treatment for Acute Lymphoblastic Leukemia

Dr. Rahul Bhargava offers cutting-edge treatments for ALL, tailored to the needs of each patient. Treatments include:

  1. Chemotherapy: The primary treatment to kill leukemia cells.
  2. Targeted Therapy: Focused drugs to attack specific cancer cell mutations.
  3. Immunotherapy: Boosting the immune system to fight leukemia cells.
  4. Stem Cell Transplant: Replacement of damaged bone marrow with healthy stem cells.
  5. Radiation Therapy: Used in specific cases, especially for T-cell ALL.

Why Choose Dr. Rahul Bhargava for ALL Treatment?

  • Expertise in Hematology: Dr. Rahul Bhargava is a leading hematologist with extensive experience in treating ALL and other blood disorders.
  • Personalized Care: Each patient receives individualized treatment plans based on their unique needs.
  • Advanced Technology: Access to cutting-edge diagnostic tools and treatment protocols.
  • Compassionate Approach: Dr. Bhargava and his team ensure holistic support for patients and their families.

Cost of Treatment and Stay in India

The cost of treating Acute Lymphoblastic Leukemia (ALL) in India is considerably more affordable compared to many Western countries, making it an ideal destination for those seeking high-quality medical care at a reasonable cost. The total cost of treatment, including hospitalization, varies depending on the type of treatment required and the duration of care. Here’s an overview of the costs:

  • Chemotherapy (per cycle):
    USD: $400 – $2,500
    INR: ₹30,000 – ₹2,00,000

  • Targeted Therapy (per month):
    USD: $1,200 – $6,000
    INR: ₹90,000 – ₹4,50,000

  • Immunotherapy (per month):
    USD: $1,500 – $7,000
    INR: ₹1,10,000 – ₹5,20,000

  • Stem Cell Transplant (Bone Marrow Transplant):
    USD: $15,000 – $30,000
    INR: ₹12,00,000 – ₹25,00,000

  • Radiation Therapy (full course):
    USD: $600 – $2,500
    INR: ₹50,000 – ₹2,00,000

  • Hospital Stay (per night):
    USD: $25 – $200
    INR: ₹2,000 – ₹15,000 per night

India offers an extensive range of treatment options for ALL, providing world-class care at a fraction of the cost compared to other countries. The affordability of treatment combined with advanced medical technology makes India an attractive choice for patients seeking treatment for Acute Lymphoblastic Leukemia.

×